Cargando…
Reduction of Polyunsaturated Fatty Acids with Tumor Progression in a Lean Non-Alcoholic Steatohepatitis-Associated Hepatocellular Carcinoma Mouse Model
Background and Aim: Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in Western countries. While obesity and diabetes are the hallmarks of NAFLD, it also develops in lean individuals in the absence of metabolic syndrome, with a prevalence of 7 percent in the U.S. and 25-30...
Autores principales: | Vlock, Elizabeth M, Karanjit, Shilpa, Talmon, Geoffrey, Farazi, Paraskevi A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477439/ https://www.ncbi.nlm.nih.gov/pubmed/32913449 http://dx.doi.org/10.7150/jca.48495 |
Ejemplares similares
-
Differential methylation patterns in lean and obese non-alcoholic steatohepatitis-associated hepatocellular carcinoma
por: Hymel, Emma, et al.
Publicado: (2022) -
Differential progression of unhealthy diet-induced hepatocellular carcinoma in obese and non-obese mice
por: Hymel, Emma, et al.
Publicado: (2022) -
Fatty Acid Elongation in Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma
por: Kessler, Sonja M., et al.
Publicado: (2014) -
Natural Progression of Non-Alcoholic Steatohepatitis to Hepatocellular Carcinoma
por: Ramai, Daryl, et al.
Publicado: (2021) -
Insufficiency of phosphatidylethanolamine N-methyltransferase is risk for lean non-alcoholic steatohepatitis
por: Nakatsuka, Atsuko, et al.
Publicado: (2016)